L-carnitine for Fatigue in COPD

Completed · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Copd, Fatigue

In brief

supplementation with L-carnitine that is available both as an FDA-approved therapy for primary carnitine deficiency, as well as widely available as an over-the-counter ergogenic aid will improve wellbeing and function measured by questionnaires in patient with chronic obstructive pulmonary disease (COPD). based on our review of literature that addition of health coaching (HC) to L-carnitine will yield greater gains.

Key facts

Study ID

NCT03008356

Run by

Mayo Clinic

People needed

33

Starts

2017-01-01

Expected to finish

2018-02-01

Last updated by the study team

2019-01-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• COPD patients with a positive screen for fatigue

You may not qualify if…

• Vulnerable population - pregnant women, prisoners, unable to provide consent
• Pre-menopausal/breastfeeding women (pregnancy category B)
• Thyroid disease
• Anticoagulation therapy
• Decompensated cardiac disease
• Chronic Kidney Disease (CKD4 or above)
• Known seizure disorder
• Active malignancy
• Exacerbation of underlying pulmonary disease or acute illness in the 6 weeks before screening
• Enrollment in the past 6 weeks or currently in a cardiac or pulmonary rehab program or other physical fitness class(es).
• Difficulty with swallowing pills

Where it is running

• Mayo Clinic in Rochester — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.